Getinge beats third-quarter profit estimates on pricing and product mix
Swedish medical device maker Getinge posted quarterly core earnings above market expectations, helped by pricing discipline and a richer product mix.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Swedish medical equipment maker Getinge said on Wednesday that its third-quarter core earnings beat market forecasts, according to Reuters. Better product mix and careful pricing were the main drivers. Adjusted EBITA climbed 18% to 1.28 billion Swedish crowns, about $129 million. Analysts had expected 1.19 billion crowns on average, based on a poll the company itself provided. Orders grew 2.6% on an organic basis, the eleventh straight quarter of growth. Getinge kept its 2026 organic sales growth forecast at 3% to 5%.
why it matters
Tariff refunds added about 45 million crowns to the quarter's margin, a one-off effect that investors will want to strip out when judging the underlying trend. Steady order growth and an unchanged outlook suggest demand for its products remains resilient.
market impact
Medtech: strong results and a held forecast support Getinge shares
tags
instruments
sources
- Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix — Reuters, 21 October 2026 at 06:45 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗